|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/81 | (2006.01) |
| (11) | Number of the document | 3110434 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15708411.2 |
| Date of filing the European patent application | 2015-02-23 | |
| (97) | Date of publication of the European application | 2017-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-19 |
| (46) | Date of publication of the claims translation | 2018-12-27 |
| (86) | Number | PCT/US2015/017152 |
| Date | 2015-02-23 |
| (87) | Number | WO 2015/127391 |
| Date | 2015-08-27 |
| (30) | Number | Date | Country code |
| 201461943617 P | 2014-02-24 | US |
| (72) |
CHAMBERLAIN, Aaron, US
LIU, Qiang, US
SCHMIDT, Mathias, US
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
Takeda GmbH, Byk-Gulden-Strasse 2, 78467 Konstanz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Sulieti UTI baltymai |
| UTI FUSION PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 12 | 289.00 EUR |
| 2027-02-23 |